← All stocks

ANI PHARMACEUTICALS INC

ANIP Net selling
CIK 0001023024 #2131 in the set updated 17 Sep 2026
Bought (120 mo)
$2.23M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$178.54M
$55.52M on a plan · $15.61M straight out of an exercise
Sold at will
$107.41M
89 of 238 sales
Net
−$176.31M
−$105.18M against sales at will

By person

26 insiders · 264 transactions
28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
$276.50K (2)
$58.70M (60) scheduled
−$58.43M
532,976
2.37%
$37.84M
MERIDIAN VENTURE PARTNERS II LP entity
10% owner
$28.62M (10)
−$28.62M
1,819,259
8.09%
$129.17M
−22.6%
Lalwani Nikhil
PRESIDENT & CEO
$200.00K (1)
$19.96M (11)
−$19.76M
339,089
1.51%
$24.08M
Gassert Chad
SVP - CORP. DEV. & STRATEGY
$275.09K (2)
$15.14M (13) scheduled
−$14.87M
233,406
1.04%
$16.57M
MARSHBANKS TRACY
Director
$12.49M (11)
−$12.49M
361,044
1.61%
$25.63M
−35.5%
CAREY STEPHEN P.
SVP & CFO
$8.41M (12) scheduled
−$8.41M
171,843
0.7640%
$12.20M
PRZYBYL ARTHUR
President and CEO
$7.80M (11)
−$7.80M
190,309
0.8461%
$13.51M
−12.1%
Marken James G.
SVP OPS & PROD DEV
$3.77M (7)
−$3.77M
117,829
0.5239%
$8.37M
+142.2%
Mutz Christopher
HEAD OF RARE DISEASE
$2.86M (11) scheduled
−$2.86M
91,309
0.4060%
$6.48M
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
$2.70M (8) scheduled
−$2.70M
87,477
0.3889%
$6.21M
+403.8%
Gutwerg Ori
SVP, GENERICS
$2.68M (10)
−$2.68M
75,534
0.3358%
$5.36M
Walsh Patrick D
Director
$707.94K (6)
$3.12M (5)
−$2.42M
38,432
0.1709%
$2.73M
RAYNOR DANIEL
Director
$2.18M (6)
−$2.18M
300,113
1.33%
$21.31M
−10.2%
Thoma Jeanne
Director
$49.82K (1)
$1.99M (3)
−$1.94M
26,762
0.1190%
$1.90M
+1,684%
Pera Antonio R
Director
$126.79K (1)
$1.82M (4)
−$1.69M
27,017
0.1201%
$1.92M
Davis Krista
SVP, CHIEF HR OFFICER
$1.62M (12) scheduled
−$1.62M
51,946
0.2310%
$3.69M
HAUGHEY THOMAS
Director
$497.20K (4)
$1.82M (2)
−$1.33M
38,878
0.1729%
$2.76M
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$911.39K (35) scheduled
−$911.39K
73,924
0.3287%
$5.25M
Leonard Matthew J
Director
$840.72K (2)
−$840.72K
11,221
0.0499%
$796.69K
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
$820.24K (3)
−$820.24K
38,271
0.1702%
$2.72M
+9.6%
TANNENBAUM RENEE P
Director
$273.81K (2)
−$273.81K
29,514
0.1312%
$2.10M
NASH DAVID
Director
$99.36K (1)
+$99.36K
38,561
0.1714%
$2.74M
Brown Robert E. JR
Director
49,021
0.2180%
$3.48M
+384.9%
HOLUBOW FRED
Director
14,811
0.0659%
$1.05M
+25.4%
Penn Thomas A.
Director
14,301
0.0636%
$1.02M
+41.5%
Gosebruch Henry O
Director
6,662
0.0296%
$473.00K
Insider
Date
Role
Action
Shares
Price
Amount
Lalwani Nikhil
15 Sep 2026
PRESIDENT & CEO
Sold on a plan
5,400
$71.00
$383.40K
Cook Meredith
14 Sep 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$70.79
$35.40K
Thoma Jeanne
11 Sep 2026
Director
Sold on a plan
1,000
$71.53
$71.53K
CAREY STEPHEN P.
31 Aug 2026
SVP & CFO
Sold on a plan
2,850
$72.80
$207.48K
Lalwani Nikhil
25 Aug 2026
PRESIDENT & CEO
Sold on a plan
5,400
$74.30
$401.22K
Cook Meredith
13 Aug 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$75.48
$37.74K
Gutwerg Ori
10 Aug 2026
SVP, GENERICS
Sell
3,162
$77.00
$243.47K
CAREY STEPHEN P.
29 Jul 2026
SVP & CFO
Sold on a plan
2,850
$81.36
$231.88K
Cook Meredith
13 Jul 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$81.84
$40.92K
CAREY STEPHEN P.
2 Jul 2026
SVP & CFO
Sold after exercise
3,313
$86.00
$284.92K
CAREY STEPHEN P.
29 Jun 2026
SVP & CFO
Sold on a plan
2,850
$84.12
$239.74K
Cook Meredith
12 Jun 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$82.03
$41.02K
HAUGHEY THOMAS
8 Jun 2026
Director
Sold on a plan
2,000
$80.88
$161.76K
CAREY STEPHEN P.
5 Jun 2026
SVP & CFO
Sold after exercise
3,312
$80.00
$264.96K
Cook Meredith
13 May 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$78.16
$39.08K
Walsh Patrick D
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Gutwerg Ori
12 May 2026
SVP, GENERICS
Sell
2,772
$79.50
$220.37K
Rowland Thomas Andrew
12 May 2026
SVP, HEAD - ESTABLISHED BRANDS
Sell
459
$79.21
$36.36K
Lalwani Nikhil
11 May 2026
PRESIDENT & CEO
Sell
55,000
$77.57
$4.27M
Walsh Patrick D
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Cook Meredith
13 Apr 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$77.95
$38.98K
Cook Meredith
13 Mar 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$72.62
$36.31K
Mutz Christopher
13 Mar 2026
HEAD OF RARE DISEASE
Sold on a plan
3,162
$71.64
$226.53K
Rowland Thomas Andrew
11 Mar 2026
SVP, HEAD - ESTABLISHED BRANDS
Sell
4,772
$74.91
$357.47K
Davis Krista
9 Mar 2026
SVP, CHIEF HR OFFICER
Sold on a plan
5,087
$74.13
$377.10K
Mutz Christopher
9 Mar 2026
HEAD OF RARE DISEASE
Sold on a plan
3,602
$74.18
$267.20K
Davis Krista
6 Mar 2026
SVP, CHIEF HR OFFICER
Sold on a plan
1,485
$75.00
$111.38K
Mutz Christopher
6 Mar 2026
HEAD OF RARE DISEASE
Sold on a plan
2,121
$74.22
$157.42K
CAREY STEPHEN P.
5 Mar 2026
SVP & CFO
Sold after exercise
4,000
$75.56
$302.24K
CAREY STEPHEN P.
5 Mar 2026
SVP & CFO
Sold after exercise
3,312
$75.42
$249.79K
Walsh Patrick D
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Gutwerg Ori
3 Mar 2026
SVP, GENERICS
Sell
2,060
$76.50
$157.59K
Mutz Christopher
2 Mar 2026
HEAD OF RARE DISEASE
Sold on a plan
417
$74.00
$30.86K
Davis Krista
20 Feb 2026
SVP, CHIEF HR OFFICER
Sold on a plan
1,730
$77.99
$134.92K
Mutz Christopher
20 Feb 2026
HEAD OF RARE DISEASE
Sold on a plan
5,323
$78.02
$415.30K
Davis Krista
19 Feb 2026
SVP, CHIEF HR OFFICER
Sold on a plan
2,084
$77.53
$161.57K
Cook Meredith
13 Feb 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$76.80
$38.40K
Mutz Christopher
12 Feb 2026
HEAD OF RARE DISEASE
Sold on a plan
7,032
$76.55
$538.30K
Cook Meredith
13 Jan 2026
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
500
$84.33
$42.17K
Davis Krista
18 Dec 2025
SVP, CHIEF HR OFFICER
Sold on a plan
1,622
$82.40
$133.65K
Cook Meredith
12 Dec 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$82.32
$32.93K
TANNENBAUM RENEE P
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Cook Meredith
13 Nov 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$87.27
$34.91K
Gassert Chad
13 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
94
$88.00
$8.27K
Walsh Patrick D
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Gassert Chad
12 Nov 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
14,642
$89.07
$1.30M
Cook Meredith
13 Oct 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$90.09
$36.04K
Davis Krista
19 Sep 2025
SVP, CHIEF HR OFFICER
Sold on a plan
1,000
$98.04
$98.04K
Cook Meredith
12 Sep 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$98.42
$39.37K
Pera Antonio R
3 Sep 2025
Director
Sell
7,292
$94.94
$692.30K
Leonard Matthew J
25 Aug 2025
Director
Sell
2,528
$90.62
$229.09K
Davis Krista
22 Aug 2025
SVP, CHIEF HR OFFICER
Sell
1,763
$91.10
$160.61K
Shanmugam Muthusamy
21 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
52,988
$90.44
$4.79M
Pera Antonio R
20 Aug 2025
Director
Sell
5,421
$89.73
$486.43K
Shanmugam Muthusamy
20 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
47,012
$90.27
$4.24M
Leonard Matthew J
18 Aug 2025
Director
Sell
6,937
$88.17
$611.64K
Thoma Jeanne
18 Aug 2025
Director
Sell
14,675
$88.87
$1.30M
Thoma Jeanne
18 Aug 2025
Director
Sell
6,865
$89.76
$616.20K
Gassert Chad
15 Aug 2025
SVP - CORP. DEV. & STRATEGY
Sell indirect
20,000
$86.97
$1.74M
Shanmugam Muthusamy
15 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
52,990
$87.15
$4.62M
Walsh Patrick D
15 Aug 2025
Director
Sell
9,000
$89.05
$801.45K
Shanmugam Muthusamy
14 Aug 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
47,010
$89.48
$4.21M
Cook Meredith
13 Aug 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$88.87
$35.55K
HAUGHEY THOMAS
12 Aug 2025
Director
Sell
19,341
$85.93
$1.66M
CAREY STEPHEN P.
12 Aug 2025
SVP & CFO
Sold after exercise
50,000
$86.07
$4.30M
Gutwerg Ori
12 Aug 2025
SVP, GENERICS
Sell
5,873
$86.53
$508.19K
Lalwani Nikhil
12 Aug 2025
PRESIDENT & CEO
Sell
56,960
$85.93
$4.89M
Rowland Thomas Andrew
12 Aug 2025
SVP, HEAD - ESTABLISHED BRANDS
Sell
4,975
$85.71
$426.41K
Cook Meredith
14 Jul 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$64.88
$25.95K
Cook Meredith
13 Jun 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$61.37
$24.55K
Gutwerg Ori
15 May 2025
SVP, GENERICS
Sell
881
$60.07
$52.92K
Mutz Christopher
14 May 2025
HEAD OF RARE DISEASE
Sell
4,000
$60.45
$241.80K
Cook Meredith
13 May 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$62.20
$24.88K
Shanmugam Muthusamy
9 May 2025
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
700
$76.83
$53.78K
Cook Meredith
14 Apr 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$68.96
$27.58K
Davis Krista
19 Mar 2025
SVP, CHIEF HR OFFICER
Sold on a plan
1,866
$65.00
$121.29K
Cook Meredith
13 Mar 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$63.33
$25.33K
Davis Krista
7 Mar 2025
SVP, CHIEF HR OFFICER
Sold on a plan
1,000
$60.86
$60.86K
Gutwerg Ori
5 Mar 2025
SVP, GENERICS
Sold after exercise
5,084
$60.00
$305.04K
Gutwerg Ori
5 Mar 2025
SVP, GENERICS
Sold after exercise
300
$60.03
$18.01K
Davis Krista
21 Feb 2025
SVP, CHIEF HR OFFICER
Sold on a plan
1,000
$60.20
$60.20K
Cook Meredith
13 Feb 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$59.54
$23.82K
Cook Meredith
13 Jan 2025
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
400
$53.92
$21.57K
CAREY STEPHEN P.
17 Dec 2024
SVP & CFO
Sell
7,500
$55.79
$418.43K
Cook Meredith
13 Dec 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$56.24
$14.06K
Davis Krista
11 Dec 2024
SVP, CHIEF HR OFFICER
Sold on a plan
1,000
$60.00
$60.00K
Lalwani Nikhil
26 Nov 2024
PRESIDENT & CEO
Sold after exercise
3,481
$58.30
$202.94K
Lalwani Nikhil
26 Nov 2024
PRESIDENT & CEO
Sold after exercise
30,000
$57.95
$1.74M
Mutz Christopher
15 Nov 2024
HEAD OF RARE DISEASE
Sell
6,500
$57.70
$375.05K
Cook Meredith
13 Nov 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$61.36
$15.34K
Cook Meredith
14 Oct 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$57.19
$14.30K
Cook Meredith
13 Sep 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$56.82
$14.21K
Cook Meredith
13 Aug 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$59.62
$14.91K
Shanmugam Muthusamy
18 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
2,743
$62.00
$170.07K
Shanmugam Muthusamy
17 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
14,257
$63.16
$900.47K
Shanmugam Muthusamy
16 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
22,000
$64.27
$1.41M
Shanmugam Muthusamy
15 Jul 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
11,000
$63.38
$697.18K
Cook Meredith
12 Jul 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$64.91
$16.23K
Gassert Chad
1 Jul 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$63.44
$1.27M
Shanmugam Muthusamy
21 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
20,000
$58.90
$1.18M
Shanmugam Muthusamy
20 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
11,447
$59.86
$685.22K
Shanmugam Muthusamy
18 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,607
$60.76
$644.48K
Shanmugam Muthusamy
17 Jun 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
7,946
$61.41
$487.96K
Cook Meredith
13 Jun 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$63.80
$15.95K
Marken James G.
7 Jun 2024
SVP OPS & PROD DEV
Exercised, kept
5,300
$57.06
$302.42K
Marken James G.
7 Jun 2024
SVP OPS & PROD DEV
Exercised, kept
7,250
$49.51
$358.95K
Gutwerg Ori
5 Jun 2024
SVP, GENERICS
Sell
2,985
$67.00
$200.00K
CAREY STEPHEN P.
4 Jun 2024
SVP & CFO
Sell
5,000
$63.58
$317.90K
Gassert Chad
3 Jun 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$64.41
$1.29M
Mutz Christopher
21 May 2024
HEAD OF RARE DISEASE
Sell
2,000
$61.61
$123.22K
Shanmugam Muthusamy
20 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
12,855
$61.81
$794.57K
Shanmugam Muthusamy
17 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
5,836
$62.09
$362.36K
TANNENBAUM RENEE P
16 May 2024
Director
Sell
2,000
$63.87
$127.74K
Shanmugam Muthusamy
16 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
16,459
$63.84
$1.05M
Shanmugam Muthusamy
15 May 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
14,850
$65.86
$978.02K
Lalwani Nikhil
14 May 2024
PRESIDENT & CEO
Sell
16,669
$66.10
$1.10M
Cook Meredith
13 May 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$67.69
$16.92K
Gassert Chad
1 May 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$66.62
$1.33M
Shanmugam Muthusamy
19 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
16,809
$65.17
$1.10M
Shanmugam Muthusamy
18 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,423
$64.98
$677.29K
Shanmugam Muthusamy
17 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
9,520
$65.40
$622.61K
Shanmugam Muthusamy
16 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
5,834
$66.20
$386.21K
Shanmugam Muthusamy
15 Apr 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
7,414
$66.33
$491.77K
Cook Meredith
12 Apr 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$67.79
$16.95K
Gassert Chad
1 Apr 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$67.25
$1.35M
Cook Meredith
13 Mar 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$66.54
$16.64K
CAREY STEPHEN P.
11 Mar 2024
SVP & CFO
Sell
7,787
$65.55
$510.44K
Gassert Chad
11 Mar 2024
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$65.81
$1.32M
Lalwani Nikhil
8 Mar 2024
PRESIDENT & CEO
Sell
16,292
$67.13
$1.09M
Shanmugam Muthusamy
8 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,000
$67.17
$671.70K
Shanmugam Muthusamy
7 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
15,085
$66.35
$1.00M
Marken James G.
7 Mar 2024
SVP OPS & PROD DEV
Sell
24,338
$66.37
$1.62M
Shanmugam Muthusamy
6 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
14,822
$65.47
$970.40K
Lalwani Nikhil
6 Mar 2024
PRESIDENT & CEO
Sell
28,965
$65.52
$1.90M
Mutz Christopher
5 Mar 2024
HEAD OF RARE DISEASE
Sell
5,000
$66.00
$330.00K
Shanmugam Muthusamy
5 Mar 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,093
$65.35
$659.58K
Pera Antonio R
4 Mar 2024
Director
Sell
7,000
$65.20
$456.40K
Cook Meredith
13 Feb 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$56.04
$14.01K
Shanmugam Muthusamy
23 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
15,000
$56.44
$846.60K
Shanmugam Muthusamy
22 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
5,692
$55.95
$318.47K
Shanmugam Muthusamy
19 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
4,524
$55.57
$251.40K
Shanmugam Muthusamy
18 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
9,784
$55.30
$541.06K
Shanmugam Muthusamy
17 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,000
$55.11
$551.10K
Shanmugam Muthusamy
16 Jan 2024
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
5,000
$55.63
$278.15K
Cook Meredith
12 Jan 2024
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$56.43
$14.11K
Shanmugam Muthusamy
19 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
25,000
$52.65
$1.32M
Shanmugam Muthusamy
18 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
13,026
$52.44
$683.08K
Shanmugam Muthusamy
15 Dec 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
11,974
$52.44
$627.92K
Cook Meredith
11 Dec 2023
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$49.21
$12.30K
Shanmugam Muthusamy
17 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
13,000
$51.00
$663.00K
Shanmugam Muthusamy
16 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
6,448
$51.66
$333.10K
Shanmugam Muthusamy
15 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
7,647
$53.64
$410.19K
Davis Krista
15 Nov 2023
SVP, CHIEF HR OFFICER
Sell
2,622
$53.81
$141.09K
Shanmugam Muthusamy
14 Nov 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
22,095
$53.17
$1.17M
Cook Meredith
13 Nov 2023
SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
250
$52.03
$13.01K
Mutz Christopher
10 Nov 2023
HEAD OF RARE DISEASE
Sell
3,000
$52.47
$157.41K
Shanmugam Muthusamy
19 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,000
$57.06
$570.60K
Shanmugam Muthusamy
18 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
6,242
$57.78
$360.66K
Shanmugam Muthusamy
17 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
8,758
$58.53
$512.61K
Shanmugam Muthusamy
16 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
13,063
$58.31
$761.70K
Shanmugam Muthusamy
13 Oct 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
11,937
$57.58
$687.33K
Gassert Chad
2 Oct 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$56.48
$1.13M
Shanmugam Muthusamy
19 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
25,333
$61.23
$1.55M
Shanmugam Muthusamy
18 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
8,425
$61.64
$519.32K
Shanmugam Muthusamy
15 Sep 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
16,242
$62.81
$1.02M
Gassert Chad
1 Sep 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$64.70
$1.29M
Shanmugam Muthusamy
29 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
25,000
$63.37
$1.58M
Shanmugam Muthusamy
28 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sell indirect
25,000
$63.06
$1.58M
Marken James G.
23 Aug 2023
SVP OPS & PROD DEV
Sold after exercise
3,932
$63.00
$247.72K
Gutwerg Ori
23 Aug 2023
SVP, GENERICS
Sold after exercise
2,059
$62.39
$128.46K
Gutwerg Ori
23 Aug 2023
SVP, GENERICS
Sold after exercise
13,502
$62.39
$842.39K
MERIDIAN VENTURE PARTNERS II LP
16 Aug 2023
10% owner
Sell
200,000
$58.50
$11.70M
Lalwani Nikhil
15 Aug 2023
PRESIDENT & CEO
Sold after exercise
11,616
$61.13
$710.09K
Shanmugam Muthusamy
15 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
22,110
$61.60
$1.36M
Pera Antonio R
14 Aug 2023
Director
Sold on a plan
3,000
$60.37
$181.11K
CAREY STEPHEN P.
14 Aug 2023
SVP & CFO
Sell
17,639
$61.37
$1.08M
Shanmugam Muthusamy
14 Aug 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
27,890
$61.15
$1.71M
Lalwani Nikhil
11 Aug 2023
PRESIDENT & CEO
Sell
56,666
$57.75
$3.27M
Gassert Chad
1 Aug 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$51.06
$1.02M
Shanmugam Muthusamy
21 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
11,500
$52.56
$604.44K
Shanmugam Muthusamy
20 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
6,000
$51.52
$309.12K
Shanmugam Muthusamy
19 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
5,969
$51.48
$307.28K
Shanmugam Muthusamy
18 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
6,700
$51.84
$347.33K
Shanmugam Muthusamy
17 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
9,831
$51.06
$501.97K
Shanmugam Muthusamy
14 Jul 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan indirect
10,000
$50.43
$504.30K
Gassert Chad
3 Jul 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$53.43
$1.07M
Shanmugam Muthusamy
22 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
13,500
$51.38
$693.63K
Gassert Chad
22 Jun 2023
SVP - CORP. DEV. & STRATEGY
Sold on a plan indirect
20,000
$51.32
$1.03M
Shanmugam Muthusamy
21 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
11,843
$51.95
$615.24K
Shanmugam Muthusamy
20 Jun 2023
HEAD OF R&D, COO-NOVITIUM OPS
Sold on a plan
14,657
$51.93
$761.14K
MERIDIAN VENTURE PARTNERS II LP
1 Dec 2022
10% owner
Sell
200,000
$38.50
$7.70M
Marken James G.
15 Aug 2022
SVP OPS & PROD DEV
Sell
5,172
$37.79
$195.46K
Marken James G.
12 Aug 2022
SVP OPS & PROD DEV
Sell
12,894
$37.04
$477.61K
Gassert Chad
21 Mar 2022
SVP - CORP. DEV. & STRATEGY
Buy indirect
5,000
$27.87
$139.34K
Walsh Patrick D
21 Mar 2022
Director
Buy
5,000
$27.76
$138.79K
Lalwani Nikhil
21 Mar 2022
PRESIDENT & CEO
Buy
7,224
$27.69
$200.00K
Gassert Chad
18 Mar 2022
SVP - CORP. DEV. & STRATEGY
Buy indirect
5,000
$27.15
$135.74K
Shanmugam Muthusamy
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Buy indirect
5,000
$27.65
$138.25K
Shanmugam Muthusamy
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Buy
5,000
$27.65
$138.25K
Thoma Jeanne
20 Dec 2021
Director
Buy
1,072
$46.47
$49.82K
Pera Antonio R
7 Dec 2021
Director
Buy
3,000
$42.26
$126.79K
HAUGHEY THOMAS
6 Dec 2021
Director
Buy
2,500
$39.38
$98.45K
Walsh Patrick D
15 Mar 2021
Director
Buy
4,000
$32.89
$131.56K
Walsh Patrick D
9 Nov 2020
Director
Buy
5,000
$25.96
$129.80K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
3,000
$30.89
$92.67K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
4,000
$30.98
$123.92K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
3,000
$30.40
$91.20K
HAUGHEY THOMAS
4 Mar 2020
Director
Buy
3,000
$45.05
$135.15K
HAUGHEY THOMAS
3 Mar 2020
Director
Buy
2,000
$45.18
$90.36K
MERIDIAN VENTURE PARTNERS II LP
20 Aug 2019
10% owner
Sell
5,512
$68.18
$375.81K
MERIDIAN VENTURE PARTNERS II LP
19 Aug 2019
10% owner
Sell
2,067
$68.30
$141.18K
MERIDIAN VENTURE PARTNERS II LP
16 Aug 2019
10% owner
Sell
26,349
$68.09
$1.79M
MERIDIAN VENTURE PARTNERS II LP
15 Aug 2019
10% owner
Sell
9,315
$69.34
$645.90K
MERIDIAN VENTURE PARTNERS II LP
14 Aug 2019
10% owner
Sell
26,360
$69.89
$1.84M
MERIDIAN VENTURE PARTNERS II LP
13 Aug 2019
10% owner
Sell
20,821
$71.77
$1.49M
MERIDIAN VENTURE PARTNERS II LP
12 Aug 2019
10% owner
Sell
21,016
$71.45
$1.50M
MERIDIAN VENTURE PARTNERS II LP
9 Aug 2019
10% owner
Sell
19,860
$71.70
$1.42M
NASH DAVID
24 May 2019
Director
Buy
1,445
$68.76
$99.36K
Marken James G.
17 May 2019
SVP Ops & Prod Dev
Sell
8,907
$70.67
$629.46K
Brown Robert E. JR
16 May 2019
Director
Exercised, kept
1,167
$33.00
$38.51K
Brown Robert E. JR
16 May 2019
Director
Exercised, kept
1,042
$6.36
$6.63K
HAUGHEY THOMAS
15 May 2019
Director
Buy
2,500
$69.30
$173.24K
PRZYBYL ARTHUR
15 May 2019
President and CEO
Sell
14,633
$69.25
$1.01M
Marken James G.
14 May 2019
SVP Ops & Prod Dev
Sell
4,917
$70.31
$345.71K
PRZYBYL ARTHUR
14 May 2019
President and CEO
Sell
5,772
$70.45
$406.64K
Schrepfer Robert W
13 May 2019
SVP - New Bus Dev & Spec Sales
Sell
2,409
$71.13
$171.35K
PRZYBYL ARTHUR
13 May 2019
President and CEO
Sell
9,595
$71.10
$682.20K
PRZYBYL ARTHUR
19 Mar 2019
President and CEO
Sold after exercise
2,823
$63.51
$179.29K
PRZYBYL ARTHUR
18 Mar 2019
President and CEO
Sold after exercise
24,802
$63.53
$1.58M
Schrepfer Robert W
13 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
4,651
$64.43
$299.65K
Schrepfer Robert W
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
1,503
$64.50
$96.94K
Schrepfer Robert W
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
5,642
$64.44
$363.58K
Schrepfer Robert W
11 Sep 2018
SVP - New Bus Dev & Spec Sales
Exercised, kept
28,688
$6.60
$189.34K
MARSHBANKS TRACY
16 May 2018
Director
Sell indirect
25,706
$62.40
$1.60M
MARSHBANKS TRACY
15 May 2018
Director
Sell indirect
7,024
$62.05
$435.84K
MARSHBANKS TRACY
14 May 2018
Director
Sell indirect
5,506
$62.35
$343.30K
MARSHBANKS TRACY
10 May 2018
Director
Sell indirect
24,229
$62.03
$1.50M
MARSHBANKS TRACY
10 May 2018
Director
Sell indirect
17,685
$62.14
$1.10M
MARSHBANKS TRACY
9 May 2018
Director
Sell indirect
20,517
$62.05
$1.27M
MARSHBANKS TRACY
18 Apr 2018
Director
Sell indirect
33,200
$62.09
$2.06M
RAYNOR DANIEL
19 Mar 2018
Director
Sell indirect
5,313
$60.62
$322.07K
RAYNOR DANIEL
15 Mar 2018
Director
Sell indirect
1,902
$61.50
$116.97K
RAYNOR DANIEL
14 Mar 2018
Director
Sell indirect
1,919
$62.02
$119.02K
PRZYBYL ARTHUR
14 Mar 2018
President and CEO
Sell
10,000
$62.03
$620.30K
MARSHBANKS TRACY
14 Mar 2018
Director
Sell indirect
1,912
$63.10
$120.65K
RAYNOR DANIEL
13 Mar 2018
Director
Sell indirect
4,117
$62.59
$257.68K
RAYNOR DANIEL
13 Mar 2018
Director
Sell indirect
14,000
$61.81
$865.34K
PRZYBYL ARTHUR
13 Mar 2018
President and CEO
Sell
6,525
$62.63
$408.66K
PRZYBYL ARTHUR
13 Mar 2018
President and CEO
Sell
23,475
$61.52
$1.44M
MARSHBANKS TRACY
12 Mar 2018
Director
Sell indirect
12,269
$63.03
$773.32K
Showing 250 of 264 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 123
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 16 Nov 2016